Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy

Journal of the American College of Cardiology

Volumn 29, Issue 4, 1997, Pages 734-740

  Rishi, Fouzia ^a   Hulse, J Edward ^a   Auld, Debbie O ^a   McRae, Guyler ^a   Kaltman, Jon ^a   Kanter, Kirk ^b   Williams, Willis ^b   Campbell, Robert M ^a  

^a Children's Healthcare of Atlanta at Egleston   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CHILD; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART PACING; HOLTER MONITORING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; PRIORITY JOURNAL;

ADOLESCENT; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HUMANS; INFANT; MALE; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0030889126     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00591-8     Document Type: Article

References (32)

1. Maron BJ, Tajik AJ, Ruttenberg HD, et al. Hypertrophic cardiomyopathy in infants clinical features and natural history . Circulation. 65:1982;7-17.
2. Fiddler GI, Tajik AJ, Weidman WH, McGoon DC, Ritter DG, Giuliani ER. Idiopathic hypertrophic subaortic stenosis in the young. Am J Cardiol. 42:1978;793-799.
3. Maron BJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Epstein SE. Asymmetric septal hypertrophy in childhood. Circulation. 53:1976;9-27.
4. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol. 13:1989;820-823.
5. Maron BJ, Spirito P, Wesley Y, Arce C. Development and Progression of Left Ventricular Hypertrophy in Children with Hypertrophic Cardiomyopathy. N Engl J Med. 315:1986;610-614.
6. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 9:1987;1013-1017.
7. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy role of age and clinical, electrographic and hemodynamic features . Am J Cardiol. 47:1981;532-538.
8. Maron JB, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy interrelations of clinical manifestations, pathophysiology, and therapy (first of two parts) . N Engl J Med. 316:1987;780-789.
9. Maron JB, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy interrelations of clinical manifestations, pathophysiology, and therapy (second of two parts) . N Engl J Med. 316:1987;844-852.
10. Tajik AJ, Giuliani ER, Weidman WH, Brandenburg RO, McGoon DC. Idiopathic hypertrophic subaortic stenosis long-term surgical follow-up . Am J Cardiol. 34:1974;815-822.
11. Canedo MI, Frank MJ. Therapy of hypertrophic cardiomyopathy: medical or surgical? clinical and pathophysiologic considerations. Am J Cardiol. 48:1981;383-388.
12. Spicer RL, Rocchini AP, Crowley DC, Rosenthal A. Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy. Am J Cardiol. 53:1984;1614-1619.
13. McIntosh CL, Maron BJ. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation. 78:1988;487-495.
14. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of HOCM. J Thorac Cardiovasc Surg. 110:1995;195-208.
15. Cohn LH, Trehan H, Collins JJ. Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 70:1992;657-660.
16. Hassenstein P, Storch H, Schmitz W. Erfahrungen mit schrittmacherdauerbehandlung bei patienten mit obstrukitver kardiomyopathie. Thoraxchirurgie. 23:1975;496-498.
17. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in HOCM. Lancet. 339:1992;1318-1323.
18. Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and β-adrenergic blocker therapy. Circulation. 85:1992;2149-2161.
19. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Circulation. 90:1994;2731-2742.
20. McDonald KM, Maurer B. Permanent pacing as treatment for hypertrophic cardiomyopathy. Am J Cardiol. 68:1991;108-110.
21. Duch HJ, Hutschenreiter W, Pankeau H, Trenchmann H. Vorhofsynchronae Ventrikelstimulation Mit Verkurtzer atrioventricular Verzogerungszeit Als Therapieprinzip De Hypertrophischen Obstruktiven Kardiomyopathie. Z Gesamte Inn Med. 39:1984;437-447.
22. Rothman KJ, Boice JD Jr. Epidemiologic analysis with a programmable calculator NIH Pub No. 79-1649 . 1979;National Institutes of Health, Bethesda (MD).
23. Klues HG, Roberts WC, Maron BJ. Anomalous insertion of papillary muscle directly into anterior mitral valve leaflet in hypertrophic cardiomyopathy significance in producing left ventricular outflow obstruction . Circulation. 84:1991;1188-1197.
24. Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR, Tajik AJ. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 27:1996;421-430.
25. Betocci S, Losi MA, Piscione F, et al. Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function. Am J Cardiol. 77:1996;498-502.
26. Maron BJ. Asymmetry in hypertrophic cardiomyopathy the septal to free wall thickness ration revisited . Am J Cardiol. 55:1985;835-838.
27. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients . J Am Coll Cardiol. 26:1995;1699-1708.
28. Park SH, Shub C, Nobrega TP, et al. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography correlation with autopsy and M-mode echocardiography . J Am Soc Echocardiogr. 9:1996;119-128.
29. Gopal AS, Keller AM, Shen Z, et al. Three dimensional echocardiography in vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiographic methods . J Am Coll Cardiol. 24:1994;504-513.
30. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-214.
31. Gillette PC, Zeigler VL. Pediatric Cardiac Pacing. 1995;Futura, Armonk (NY).
32. Maron BJ. Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy too soon for a rush to judgment? J Am Coll Cardiol. 27:1996;431-432.